Similar articles

• A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.

  Lopez Bernaldo de Quiros JC, Miro JM, Peña JM, Podzamczer D, Alberdi JC, Martínez E, Cosin J, Claramonte X, Gonzalez J, Domingo P, Casado JL, Ribera E; Grupo de Estudio del SIDA 04/98. Lopez Bernaldo de Quiros JC, et al. N Engl J Med. 2001 Jan 18;344(3):159-67. doi: 10.1056/NEJM200101183440301. N Engl J Med. 2001. PMID: 11172138 Clinical Trial.
• Discontinuing prophylaxis against Pneumocystis carinii pneumonia.

  Le Moal G, Breux JP, Roblot F. Le Moal G, et al. N Engl J Med. 2001 May 24;344(21):1639-41. doi: 10.1056/NEJM200105243442113. N Engl J Med. 2001. PMID: 11374363 No abstract available.
• Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.

  Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M, Uberti-Foppa C, Pradier C, D'Arminio Monforte A, Schneider MM, Lundgren JD; Eight European Study Groups. Ledergerber B, et al. N Engl J Med. 2001 Jan 18;344(3):168-74. doi: 10.1056/NEJM200101183440302. N Engl J Med. 2001. PMID: 11188837
• Pneumocystis pneumonia in a person with a low CD4 count after stopping antiretroviral therapy.

  Ball SC. Ball SC. AIDS Read. 2007 Dec;17(12):583-6, 593. AIDS Read. 2007. PMID: 18178976 Review.
• [The prevention of Pneumocystis carinii pneumonia in HIV infection].

  Rockstroh JK, Spengler U, Sauerbruch T. Rockstroh JK, et al. Dtsch Med Wochenschr. 1993 Nov 19;118(46):1694-7. doi: 10.1055/s-2008-1059504. Dtsch Med Wochenschr. 1993. PMID: 8243242 Review. German. No abstract available.